19 February 2014Big Pharma
Therapeutic use claims: assessing 'effective' treatment
Several significant patent cases were heard by the UK courts over the course of the last year and common themes are emerging which impact on the life sciences industry, in particular in the context of second medical use claims and dosage regimes.
